The Scripps Research Institute-医療機器分野:企業M&A・提携分析

◆英語タイトル:The Scripps Research Institute - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011235
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institute offers technology and scientific services such as antibody development and production, cell based screening, high performance computing, normal blood donor service and murine behavioral assessment, among others. It also offers undergraduate, graduate and postdoctoral programs. TSRI also organizes academic preparation and educational outreach programs. The institute operates through its research centers and institutes including Integrative Molecular Biosciences, Center for Metabolomics, Dorris Neuroscience Center, Molecular Screening Center, and others. TSRI is headquartered in La Jolla, California, the US.

The Scripps Research Institute – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
The Scripps Research Institute, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
The Scripps Research Institute, Medical Equipment Deals By Type, 2011 to YTD 2017 7
The Scripps Research Institute, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
The Scripps Research Institute, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
The Scripps Research Institute, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
The Scripps Research Institute, Medical Equipment, Deal Details 11
Partnerships 11
Pfizer Enters into Licensing Agreement with Scripps Research Institute 11
Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 12
Brooks Life Science Enters Into Licensing Agreement With The Scripps Research Institute 13
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 14
Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 15
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 16
The Scripps Research Institute – Key Competitors 17
The Scripps Research Institute – Key Employees 18
The Scripps Research Institute – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Corporate Communications 21
Nov 30, 2017: The Scripps Research Institute welcomes renowned data scientist Amalio Telenti 21
Jun 01, 2016: TSRI Appoints Richard King as Chief Operating Officer 22
Product News 23
Oct 13, 2017: Scripps Florida Scientists Unveil ‘Roadmap’ to Aid Osteoporosis Treatment Development 23
Oct 11, 2017: TSRI Chemists Use Modified DNA Nucleotides to Create New Materials 24
Sep 28, 2017: TSRI Researchers Get a Lead on How to Detect Degenerative Neurological Diseases Sooner 26
Aug 23, 2017: TSRI Researchers Develop Assay to Help Identify New Pain Medication Candidates 27
Jun 01, 2017: Global Virus Network Center of Excellence TSRI Investigation Reveals First-Ever Image of Elusive Viral Protein 28
Feb 22, 2017: TSRI Researchers Find Standard Pacemakers and Defibrillators Safe for MRI Using a New Protocol 30
Aug 08, 2016: TSRI Scientists Pinpoint Ebola’s Weak Spots 32
May 19, 2016: New HIV-Mimicking Particles That Trigger Immune Response Could Advance AIDS Vaccine Design 34
Mar 15, 2016: TSRI Scientists Identify Molecular Markers of Kidney Transplant Rejection 35
Feb 19, 2016: TSRI and JCVI scientists find popular stem cell techniques safe 37
Feb 18, 2016: Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor 38
Feb 10, 2016: Scripps Florida Researchers Develop ‘LIGHTSABR’—A Cheap, Portable Drug-Discovery System 40
Jan 28, 2016: TSRI Study Reveals Workings of Mysterious ‘Relief Valve’ that Protects Cells from Swelling 42
Jan 25, 2016: Crouching Protein, Hidden Enzyme : The Scripps Research Institute 44
Other Significant Developments 46
Oct 25, 2017: New ResearchKit App from The Scripps Research Institute Looks at How Genetic Risk Influences Heart Health Decisions 46
Jul 21, 2016: The Scripps Research Institute Leverages Powerful End-to-End DDN Storage to Help Reveal Secrets to New Medical Treatments 47
Jul 06, 2016: TSRI Awarded $20 Million for First Year of Precision Medicine Initiative Cohort Program 48
May 04, 2016: Scripps Research Institute Spin-off iGenomX Launches with Transformational New Library Construction Technology for DNA Sequencing 50
Jan 27, 2016: Philanthropist Samuel Yin Provides $12.8 Million Gift for New Laboratories at The Scripps Research Institute 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
The Scripps Research Institute, Medical Equipment, Key Facts 2
The Scripps Research Institute, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
The Scripps Research Institute, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
The Scripps Research Institute, Medical Equipment Deals By Type, 2011 to YTD 2017 7
The Scripps Research Institute, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
The Scripps Research Institute, Deals By Market, 2011 to YTD 2017 9
The Scripps Research Institute, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Pfizer Enters into Licensing Agreement with Scripps Research Institute 11
Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 12
Brooks Life Science Enters Into Licensing Agreement With The Scripps Research Institute 13
NeuroMetrix Enters into Agreement with Scripps Translational Science Institute 14
Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 15
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 16
The Scripps Research Institute, Key Competitors 17
The Scripps Research Institute, Key Employees 18
The Scripps Research Institute, Other Locations 19
The Scripps Research Institute, Subsidiaries 19
The Scripps Research Institute, Joint Venture 20

★海外企業調査レポート[The Scripps Research Institute-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BlackRock Inc:企業の戦略・SWOT・財務情報
    BlackRock Inc - Strategy, SWOT and Corporate Finance Report Summary BlackRock Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Securitas AB:戦略・SWOT・企業財務分析
    Securitas AB - Strategy, SWOT and Corporate Finance Report Summary Securitas AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ULURU Inc (ULUR):医療機器:M&Aディール及び事業提携情報
    Summary ULURU Inc (ULURU) is a medical technology company that researches, develops, and markets wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wo …
  • Georg Fischer AG:企業の戦略・SWOT・財務情報
    Georg Fischer AG - Strategy, SWOT and Corporate Finance Report Summary Georg Fischer AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析
    Summary Wave Life Sciences Ltd (Wave Life Sciences) formerly WAVE Life Sciences Pte Ltd, discovers, develops and commercializes medicines for genetic diseases. The company's pipeline comprises an mRNA transcript candidates: WVE-120101 and WVE-120102 for Huntington's disease; ATXN3 gene candidate for …
  • Cebu Air Inc:企業の戦略・SWOT・財務情報
    Cebu Air Inc - Strategy, SWOT and Corporate Finance Report Summary Cebu Air Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • MetGen Oy:電力:M&Aディール及び事業提携情報
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company offers metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosic …
  • China Metallurgical Group Corp (1618):企業の財務・戦略的SWOT分析
    China Metallurgical Group Corp (1618) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Globus Medical Inc (GMED):企業の財務・戦略的SWOT分析
    Globus Medical Inc (GMED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lixil Group Corporation (5938):企業の財務・戦略的SWOT分析
    Lixil Group Corporation (5938) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Nisshinbo Holdings Inc. (3105):企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc. (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Emerson Electric Co.:戦略・SWOT・企業財務分析
    Emerson Electric Co. - Strategy, SWOT and Corporate Finance Report Summary Emerson Electric Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • TUI AG (TUI1):企業の財務・戦略的SWOT分析
    TUI AG (TUI1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • McCarthy Building Companies Inc:企業の戦略的SWOT分析
    McCarthy Building Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Nippon Paper Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Metagenics Inc:企業の戦略的SWOT分析
    Metagenics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Trinity Health:企業の戦略的SWOT分析
    Trinity Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Noranda Income Fund (NIF.UN):企業の財務・戦略的SWOT分析
    Noranda Income Fund (NIF.UN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Battalion Oil Corp (HKRSQ):企業の財務・戦略的SWOT分析
    Summary Battalion Oil Corp (Battalion Oil), formerly Halcon Resources Corp, is an independent energy company that carries out the acquisition, production, exploration and development of onshore oil and natural gas properties. Battalion Oil mainly focuses on the Delaware Basin, East Texas. The compan …
  • Toagosei Co., Ltd.:企業の戦略・SWOT・財務分析
    Toagosei Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toagosei Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆